Drug intelligence / Profile preview

Omeza Skin Protectant

Development stage: Unknown
Lead developer: Omeza
Modality: Small Molecules
Administration: Topical

Overview

Omeza Skin Protectant is an over-the-counter (OTC) topical gel developed by Omeza LLC, a skin health company based in Sarasota, Florida. The product's active ingredient is cod liver oil, which functions as an anhydrous skin protectant intended to temporarily protect and relieve minor skin irritation and itching caused by rashes and eczema. It is part of Omeza's broader marine-based regenerative product line, which also includes the Omeza Collagen Matrix (OCM) for chronic wound care. In December 2023, the FDA issued a warning letter to the developer, classifying Omeza Skin Protectant as an unapproved new drug because it does not conform to the conditions of the OTC monograph for skin protectants.

Brand names: Omeza Skin Protectant
Other names: Omeza

Beyond the preview

Go deeper on Omeza Skin Protectant.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omeza Skin Protectant.

Explore the full profile